Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8501703 Chimeric oligomeric compounds for modulation of splicing

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

August 6, 2013

Patent Application Number

12065250

Date Filed

August 29, 2006

Patent Citations Received

US Patent 12104156 Compositions and methods of treating facioscapulohumeral muscular dystrophy

0

US Patent 12060558 Methods and compositions for treatment of cholesteryl ester storage disease

0

US Patent 12064483 Nucleic acid-polypeptide compositions and methods of inducing exon skipping

0

US Patent 12071621 Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping

0

US Patent 11712478 Compositions and methods of treating muscle atrophy and myotonic dystrophy

0

US Patent 11834661 Angiotensinogen (AGT) iRNA compositions and methods of use thereof

0

US Patent 11872287 Compositions and methods of treating muscle atrophy and myotonic dystrophy

0

US Patent 11873490 Antisense oligomers for treatment of conditions and diseases

0

...

Patent Primary Examiner

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8501703 Chimeric oligomeric compounds for modulation of splicing

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool